Clinical trial
Safety of MOON101 for the Treatment of Peanut Allergy
NCT07580898 is registered in ClinicalTrials.gov with Moonlight Therapeutics, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety of MOON101 for the Treatment of Peanut Allergy
- Lead sponsor
- Moonlight Therapeutics, Inc.
- Phase
- Phase 1
- Overall status
- Active, not recruiting
- Start date
- June 29, 2026
- Completion date
- December 31, 2027
- Enrollment
- 40 (estimated)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
peanut allergy